GeoVax Labs Inc.

NASDAQ: GOVX · Real-Time Price · USD
0.75
-0.00 (-0.13%)
At close: Aug 15, 2025, 1:11 PM

GeoVax Labs Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
3.95M n/a 81K 385K
Cost of Revenue
95.37K 20.72M 56.28K 15.55M
Gross Profit
3.86M -20.72M 24.72K -15.17M
Operating Income
-25.14M -26.74M -14.03M -18.75M
Interest Income
173.36K 776.18K 7.44K 4.74K
Pretax Income
-24.99M -25.97M -14.02M -18.57M
Net Income
-24.99M -25.97M -14.01M -18.53M
Selling & General & Admin
5.39M 5.95M 4.99M 3.58M
Research & Development
23.71M 20.72M 9.12M 15.55M
Other Expenses
n/a -20.65M 7K 176K
Operating Expenses
29M 6.02M 14.11M 19.13M
Interest Expense
21.38K n/a n/a 1.29K
Selling & Marketing Expenses
n/a -74.17K n/a n/a
Cost & Expenses
29.1M 26.74M 14.11M 19.13M
Income Tax Expense
n/a n/a -7.44K -38.52K
Shares Outstanding (Basic)
5.19M 2.54M 2.54M 2.54M
Shares Outstanding (Diluted)
5.19M 2.54M 2.54M 2.54M
EPS (Basic)
-4.82 -10.22 -5.52 -7.3
EPS (Diluted)
-4.82 -10.22 -5.52 -7.3
EBITDA
-24.88M -26.67M -13.97M -18.53M
EBIT
-24.97M -26.74M -14.03M -18.57M
Depreciation & Amortization
95.37K 74.17K 56.28K 38.52K